Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

The company will begin its domestic investment by starting construction on a $3 billion pharmaceutical manufacturing site in ...

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...

Ajinomoto Bio-Pharma Services and Olon S.p.A. have entered into a strategic partnership to deliver drug substance manufacturing services.

Researchers at the Indian Institute of Science (IISc) have developed a highly efficient cell-free enzyme system that converts ...

Success with a smart VF is less about the screens and more about how people interact with the data and each other.

Learn how a nutraceutical brand is investing in responsible and transparent manufacturing.

Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.

The partnership will accelerate efficient and sustainable manufacturing of high-demand proteins and peptides, such as GLP-1 analogs, for pharmaceutical and biotechnology clients TOKYO ...